Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00764569 · ClinicalTrials.gov registry record
The Investigation of a Fluorescence/Elastic Scattering Spectroscopy (F-ESS) Device for Oral Tissue Characterization
A clinical trial of Other Lesions of Oral Mucosa, sponsored by University of California, Irvine.
- Completed
- Registry status
- 77
- Enrollment target
- 2
- Study locations
NCT00764569: Completed study of Other Lesions of Oral Mucosa, sponsored by University of California, Irvine.
NCT00764569 is a study of Other Lesions of Oral Mucosa that has completed, run by University of California, Irvine. The registered enrollment target is 77 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00764569, a study of Other Lesions of Oral Mucosa, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 77 participants
- Enrollment target
- 2
- Study locations
Study Summary
The overall objective of this work is to identify changes in the optical properties of oral tissues to develop a non-invasive tool for the detection, diagnosis and screening of oral pathology so that treatment can be provided at the earliest possible time.
Primary Outcome
Fluorescence/Elastic Scattering Spectroscopy Oral tissue measurement
Conditions Studied
Interventions
- DEVICE Fluorescence/Elastic Scattering Spectroscopy
Study Locations (2)
California
- Beckman Laser Institute Medical clinic - Irvine
- UCI student health center - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2008-11 |
| Est. Completion | 2011-06 |
What the finished NCT00764569 record still lists
NCT00764569 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 77 participants, a relatively small participant target.
The record links to 1 condition, with Other Lesions of Oral Mucosa appearing as the primary indexed condition, and to 1 intervention - of which Fluorescence/Elastic Scattering Spectroscopy is the first listed.
NCT00764569 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00764569 about?
NCT00764569 is a clinical study titled "The Investigation of a Fluorescence/Elastic Scattering Spectroscopy (F-ESS) Device for Oral Tissue Characterization". The overall objective of this work is to identify changes in the optical properties of oral tissues to develop a non-invasive tool for the detection, diagnosis and screening of oral pathology so that treatment can be provided at the earliest possible time.
What is the current status of trial NCT00764569?
This trial is currently completed. The enrollment target is 77 participants. The study started on 2008-11. Estimated completion is 2011-06.
What conditions does trial NCT00764569 study?
This clinical trial studies the following conditions: Other Lesions of Oral Mucosa.
What interventions are being tested in trial NCT00764569?
The interventions under investigation include: Fluorescence/Elastic Scattering Spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT00764569?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00764569 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia